Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2026-01-03 @ 6:23 AM
Study NCT ID:
NCT05831969
Status:
UNKNOWN
Last Update Posted:
2023-04-26
First Post:
2023-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenalidomide to Reverse Drug Resistance After First-line Treatment of Advanced HCC
Sponsor:
Shenyang Tenth People's Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Dream-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |